Boston Scientific (BSX) Change in Receivables (2020 - 2026)

Boston Scientific has disclosed Change in Receivables across 7 years of filings, most recently posting $46.0 million for Q2 2026.

• In Q2 2026, Change in Receivables rose 43.75% year-over-year to $46.0 million; the TTM figure through Jun 2026 stood at $293.0 million (up 11.83% YoY), while the FY2025 annual figure was $269.0 million, down 23.36% from the prior year.
• Change in Receivables came in at $46.0 million for Q2 2026 at Boston Scientific, down from $117.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $117.0 million in Q1 2026 to a low of $3.0 million in Q3 2023.
• Average Change in Receivables over 5 years is $68.9 million, with a median of $74.5 million recorded in 2023.
• Year-over-year, Change in Receivables sank 78.57% in 2023 and surged 1000.0% in 2024.
• Over 5 years, Change in Receivables stood at $44.0 million in 2022, then jumped by 68.18% to $74.0 million in 2023, then increased by 21.62% to $90.0 million in 2024, then climbed by 8.89% to $98.0 million in 2025, then slumped by 53.06% to $46.0 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $46.0 million in Q2 2026, $117.0 million in Q1 2026, and $98.0 million in Q4 2025.